Why the study?
Does diabetic autonomic neuropathy affect epinephrine secretion and hypoglycemia awareness during insulin-induced hypoglycemia?
Does diabetic autonomic neuropathy affect epinephrine secretion and hypoglycemia awareness during insulin-induced hypoglycemia?
Diabetic autonomic neuropathy is associated with impaired epinephrine secretion, leading to hypoglycemia unawareness and increased risk of severe hypoglycemia.
Answers are grounded in this paper and cite their sources.
May increase severe hypoglycemia risk via unawareness; hypothesis-generating and requires prospective validation before guiding practice.
The cause of susceptibbility of certain diabetic patients to severe hypoglycemia is not known. Because the awareness of hypoglycemia is heightened by catecholamine-mediated physiologic responses, deficient catecholamine secretion may cause frequent and severe hypoglycemia. Plasma epinephrine and norepinephrine were measured after insulin-induced hypoglycemia in 18 diabetic patients, nine with autonomic neuropathy, and in nine normal volunteers. Our results show that two thirds of patients with diabetic autonomic neuropathy have moderate to severe deficits in epinephrine secretion and that these patients have diminished or delayed subjective responses to low blood sugar and are at risk for developing severe hypoglycemia and its neurologic consequences.
No takes yet. Share an insight, caveat, or question.
Robert D. Hoeldtke (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: